+160.2%
CIFR vs CVS
+31.0%
+129.2%
-81.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.4% | -1.6% | +0.2% | -0.9% |
| 7D | -9.4% | -10.9% | +1.5% | -6.2% |
| 30D | -27.0% | -14.9% | -12.1% | -23.2% |
| 3M | -59.2% | -13.9% | -45.3% | -57.4% |
| 6M | -65.5% | -13.9% | -51.7% | -64.1% |
| YTD | -56.1% | +4.0% | -60.1% | -58.0% |
| 1Y | -55.7% | +7.8% | -63.4% | -58.3% |
| All | +160.2% | +31.0% | +129.2% | +145.0% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling